2025
SJR Q2
OA
1 matched articles
Journal detail
Neuropsychopharmacology Reports
- Publisher
- John Wiley & Sons Inc.
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
2574173X
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,561
- Quartile Q2
- H-Index 27
- Cites/doc 2,05
- Docs (3y) 260
- Cites (3y) 507
Clarivate
Web of Science · JCR
No JCR match
Subject classification
Categories (SJR)
- Clinical Psychology Q2
- Pharmacology Q3
- Pharmacology (medical) Q3
- Psychiatry and Mental Health Q3
Areas
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
- Psychology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | — | 0,561 | — | — | — | — | 27 |
| 2024 | Q2 | — | 0,602 | — | — | — | — | 24 |
| 2023 | Q2 | — | 0,66 | — | — | — | — | 24 |
| 2022 | Q2 | — | 0,651 | — | — | — | — | 24 |
| 2021 | Q2 | — | 0,579 | — | — | — | — | 24 |
| 2020 | Q2 | — | 0,661 | — | — | — | — | 24 |
| 2019 | Q3 | — | 0,334 | — | — | — | — | 24 |
| 2016 | — | — | — | — | — | — | — | 24 |
| 2015 | — | — | — | — | — | — | — | 24 |
| 2014 | — | — | — | — | — | — | — | 24 |
| 2013 | — | — | — | — | — | — | — | 24 |
| 2011 | — | — | — | — | — | — | — | 24 |
| 2010 | — | — | — | — | — | — | — | 24 |